Skip to main content

FR
EN

Drupal

Main navigation EN

About Crossject
Our technology
Therapeutic areas

Main navigation 2 EN

Finances
News
- Our news
- Press releases
Careers
- Working at Crossject
Contact

Search

Enter the terms you wish to search for.

Home
Finances
Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe

Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe

Image

Date de parution

2024/05/02

PDF du document

2024-05- 02- Crossject_Press release_Extension_EN (2).pdf185.47 KB

FINANCES CONTACT

Natasha DRAPEAU

+41 76 823 7527

Last financial releases

Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe

2024/05/02

Crossject reports audited financial results for 2023

2024/04/25

Crossject advances in its U.S. Strategy and reports Financial Results for 2023

2024/04/02

Menu Pied de page

News
Legal information
Sitemap
Privacy Terms
Cookies

FOLLOW US